Nicotine Science and Policy
By Harry Shapiro Aug. 13, 2026
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
October 21, 2026 by medium.com
Teen Nicotine Use is at a 50-Year Low
Nicotine use among American teenagers may be at its lowest level in 50 years, according to an analysis of long-term national survey data by Charles A. Gardner.
Youth cigarette smoking has declined dramatically, while vaping has also fallen substantially in recent years. Although differences in historical survey methods make the exact 50-year comparison uncertain, the overall downward trend is clear.
These findings offer important context for tobacco harm reduction, highlighting the need to recognise progress in youth prevention while maintaining access to lower-risk alternatives for adults who smoke.
October 21, 2026 by protectingtaxpayers.org
Handed Nicotine Rules Should be Eliminated to Help Smokers Quit
Pennsylvania's new nicotine regulations under Act 57 could significantly restrict access to smoke-free alternatives, with only 159 products included on the state's approved list.
The Taxpayers Protection Alliance warns that these restrictions may limit consumer choice, affect small retailers and encourage illicit trade. With around 1.4 million adults smoking in Pennsylvania, the potential consequences for tobacco harm reduction deserve attention. Effective regulation should balance product safety and youth protection with access to lower-risk alternatives for adults seeking to quit smoking.
October 20, 2026 by substack.com
Worse Than Big Tobacco - The Researchers Helping to Protect Cigarette Sales
Research from the University of Stirling examining restrictions on retail displays of vapes and nicotine pouches has prompted criticism over its focus on reducing product appeal without assessing potential consequences for smoking cessation.
Making smoke-free alternatives less visible may discourage adult smokers from considering products that could help them quit cigarettes. The debate highlights an important gap between measuring consumer perceptions and evaluating actual public health outcomes. Tobacco control research should consider both youth protection and the potential impact of restrictions on harm reduction.
11.80% of the adult population are current smokers. There are approximately 6.7 million current smokers in United Kingdom 13.60% of men are current smokers but only 10.10% of women.
SOURCE: GSTHR
October 20, 2026 by tobaccoharmreduction.net
Popcorn Lung Myth: Why Health Sites Still Get It Wrong
The persistent association between vaping and “popcorn lung” highlights how incomplete scientific communication can distort perceptions of health risks.
Although diacetyl, a flavouring chemical linked to occupational lung disease, was previously detected in some e-cigarettes, no confirmed cases of popcorn lung have been attributed to vaping. The chemical has also been prohibited in regulated e-liquids in the UK and EU for years.
Continued references to this risk without appropriate context may discourage smokers from switching to lower-risk alternatives. Accurate public health messaging must distinguish between potential hazards, actual exposure and established evidence.
October 20, 2026 by tobaccoinsider.com
Generational Tobacco Ban
Generational tobacco bans are gaining momentum worldwide, with the UK and Maldives introducing legislation to permanently restrict tobacco sales to people born after specific dates. Similar measures are under consideration in Canada, Ireland, Türkiye and Vietnam, while New Zealand previously repealed its proposed ban.
Although these policies aim to prevent future smoking, their implications for tobacco harm reduction deserve attention. Restrictions that extend to smoke-free nicotine alternatives could limit opportunities to move away from combustible tobacco. Effective tobacco control should combine youth protection with evidence-based regulation that recognises differences in product risk.
- Page 1 of 46
Blogs
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
Harry’s blog 133: Silence is consent
Two tobacco control consultations that demand your attention
I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.